Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras

Vaccine

Volumn 29, Issue 16, 2011, Pages 3083-3088

  Jacups, Susan P ^a,b   Morris, Peter S ^a,c   Leach, Amanda J ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b CHARLES DARWIN UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

Haemophilus influenzae type b; Indigenous Australian; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; AUSTRALIA; CHILD; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CENTER; HUMAN; INDIGENOUS PEOPLE; INFANT; MAJOR CLINICAL STUDY; NEWBORN; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER STATE; CHILD; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; MALE; NASOPHARYNX; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; POLYSACCHARIDES, BACTERIAL; PREVALENCE; VACCINATION;

EID: 79953168373     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.030     Document Type: Article

References (50)

1. Centres for Disease Control and Prevention. Haemophilus influenzae serotype b (Hib) disease. Atlanta: Department of Health and Human services; 2007 [cited 2007 05/04/2007]. Available from: http://www.cdc.gov/ncidod/dbmd/diseaseinfo/haeminfluserob_t.htm.
2. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000, 13(April (2)):302-317.
3. World Health Organisation. Haemophilus influenzae type b (Hib). Geneva; 2008 [cited 2008 20/11/08]; WHO position paper. Available from: http://www.who.int/immunization/topics/hib/en/index.html.
4. Shapiro E.D., Ward J.I. The epidemiology and prevention of disease caused by Haemophilus influenzae type b. Epidemiol Rev 1991, 13:113-142.
5. Barenkamp S.J., Granoff D.M., Munson R.S. Outer-membrane protein subtypes of Haemophilus influenzae type b and spread of disease in day-care centers. J Infect Dis 1981, 144(September (3)):210-217.
6. Granoff D.M., Gilsdorf J., Gessert C., Basden M. Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin. Pediatrics 1979, 63(March (3)):397-401.
7. Li K.I., Dashefsky B., Wald E.R. Haemophilus influenzae type b colonization in household contacts of infected and colonized children enrolled in day care. Pediatrics 1986, 78(July (1)):15-20.
8. Ward J.I., Gorman G., Phillips C., Fraser D.W Hemophilus influenzae type b disease in a day-care center. Report of an outbreak. J Pediatr 1978, 92(May (5)):713-717.
9. Renner L.A., Newman M.J., Ahadzie L., Antwi-Agyei K.O., Eshetu M. Introduction of Haemophilus influenzae type B conjugate vaccine into routine immunization in Ghana and its impact on bacterial meningitis in children younger than five years. Pediatric Infect Dis J 2007, 26(April (4)):356-358.
10. Morris S.K., Moss W.J., Halsey N. Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis 2008, 8(July (7)):435-443.
11. Lucher L.A., Reeves M., Hennessy T., Levine O.S., Popovic T., Rosenstein N., et al. Reemergence, in southwestern Alaska, of invasive Haemophilus influenzae type b disease due to strains indistinguishable from those isolated from vaccinated children. J Infect Dis 2002, 186(October (7)):958-965.
12. Singleton R., Bulkow L.R., Levine O.S., Butler J.C., Hennessy T.W., Parkinson A. Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage. J Pediatr 2000, 137(September (3)):313-320.
13. Singleton R., Hammitt L., Hennessy T., Bulkow L., DeByle C., Parkinson A., et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics 2006, 118(August (2)):e421-e429.
14. Markey P. The effect of conjugate Hib vaccines on the incidence of invasive Hib disease in the NT. North Territory Dis Control Bull 1998, 5(1):3-6.
15. Markey P., Krause V., Boslego J.W., Coplan P.M., Dargan J.M., Kaplan K.M. The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register data. Epidemiol Infect 2001, 126(February (1)):31-36.
16. Communicable Diseases Australia. Notification rate of Haemophilus influenzae type b, Australia. Canberra: Commonwealth Department of Health and Ageing; 2008 [cited 2009 07/10/2008]. Available from: http://www.health.gov.au/cda/Source/Rpt_4.cfm.
17. Hains J. Two cases of Hib in a Central Australian community. North Territory Dis Control Bull 1999, 6(2):6-8.
18. Baggett H.C., Hennessy T.W., Bulkow L., Romero-Steiner S., Hurlburt D., Holder P., et al. Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska. Clin Vaccine Immunol 2006, 13(June (6)):620-626.
19. Northern Territory Depertment of Health and Families. Childhood vaccination schedule. Darwin: Northern Territory Department of Health and Families; 2008 [cited 2008 07/10/2008]. Available from: http://www.nt.gov.au/health/vaccination.
20. Chapin K.C., Doern G.V. Selective media for recovery of Haemophilus influenzae from specimens contaminated with upper respiratory tract microbial flora. J Clin Microbiol 1983, 17(June (6)):1163-1165.
21. Leach A.J., Boswell J.B., Asche V., Nienhuys T.G., Mathews J.D. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatric Infect Dis J 1994, 13(November (11)):983-989.
22. Smith-Vaughan H.C., Sriprakash K.S., Leach A.J., Mathews J.D., Kemp D.J. Low genetic diversity of Haemophilus influenzae type b compared to nonencapsulated H. influenzae in a population in which H. influenzae is highly endemic. Infect Immun 1998, 66(July (7)):3403-3409.
23. Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 1997, 21(June (13)):173-176.
24. Guthridge S., McIntyre P., Isaacs D., Hanlon M., Patel M. Differing serologic responses to an Haemophilus influenzae type b polysaccharide-neisseria meningitidis outer membrane protein conjugate (PRP-OMPC) vaccine in Australian Aboriginal and caucasian infants-implications for disease epidemiology. Vaccine 2000, 18(May (23)):2584-2591.
25. Horby P., Gilmour R., Wang H., McIntyre P. Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000. Commun Dis Intell 2003, 27(3):324-341.
26. Claesson B.A. Epidemiology of invasive Haemophilus influenzae type b disease in Scandinavia. Vaccine 1993, 11(Suppl. 1):S30-S33.
27. Kelly D.F., Moxon E.R., Pollard A.J. Haemophilus influenzae type b conjugate vaccines. Immunology 2004, 113(October (2)):163-174.
28. Perdue D.G., Bulkow L.R., Gellin B.G., Davidson M., Petersen K.M., Singleton R.J., et al. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA 2000, 283(June (23)):3089-3094.
29. Galil K., Singleton R., Levine O.S., Fitzgerald M.A., Bulkow L., Getty M., et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999, 179(January (1)):101-106.
30. Oh S.Y., Griffiths D., John T., Lee Y.C., Yu L.M., McCarthy N., et al. School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom. J Infect Dis 2008, 197(May (9)):1275-1281.
31. Heath P.T., Bowen-Morris J., Griffiths D., Griffiths H., Crook D.W., Moxon ER Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T. Arch Dis Childhood 1997, 77(December (6)):488-492.
32. Murphy T.V., Pastor P., Medley F., Osterholm M.T., Granoff D.M. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993, 122(April (4)):517-523.
33. Barbour M.L. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis 1996, 2(July-September (3)):176-182.
34. Kauppi M., Eskola J., Kayhty H. Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatric Infect Dis J 1995, 14(April (4)):286-294.
35. Fernandez J., Levine O.S., Sanchez J., Balter S., LaClaire L., Feris J., et al. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration. J Infect Dis 2000, 182(November (5)):1553-1556.
36. McVernon J., Howard A.J., Slack M.P., Ramsay M.E. Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiol Infect 2004, 132(August (4)):765-767.
37. Barbour M.L., Mayon-White R.T., Coles C., Crook D.W., Moxon E.R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995, 171(January (1)):93-98.
38. Takala A.K., Eskola J., Leinonen M., Kayhty H., Nissinen A., Pekkanen E., et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991, 164(November (5)):982-986.
39. Castillo-Febres O., Lopez G., Ortegal F., Estopinan M., Casanova-Escalona L., Sanchez-Naveda M., et al. Oropharyngeal carriers in Venezuelan children in two child care settings, vaccinated or not with Haemophilus influenzae type b tetanus toxoid conjugate vaccine (PRP-T). Invest Clin 2005, 46(March (1)):15-24.
40. Millar E.V., O'Brien K.L., Levine O.S., Kvamme S., Reid R., Santosham M. Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. Am J Public Health 2000, 90(October (10)):1550-1554.
41. Hanna J. The epidemiology and prevention of Haemophilus influenzae infections in Australian Aboriginal children. J Paediatr Child Health 1992, 28(October (5)):354-361.
42. Matos D.C., Silva A.M., Neves P.C., Martins R.M., Homma A., Marcovistz R. Pattern of functional antibody activity against Haemophilus influenzae type B (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine. Braz J Med Biol Res 2009, 42(December (12)):1242-1247.
43. Ladhani S., Slack M.P., Heys M., White J., Ramsay M.E. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Childhood 2008, 93(August (8)):665-669.
44. Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine. MMWR Morb Mortal Wkly Rep; 2009;58(September (36)):1008-9.
45. Thisyakorn U., Pancharoen C., Chuenkitmongkol S., Ortiz E. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine. Southeast Asian J Trop Med Public Health 2009, 40(March (2)):282-294.
46. Abbasi Z., Aboriginal Torres Strait Islander people 1998, Australian Bureau of Statistics, Canberra.
47. Leach A.J., Morris P.S., Mathews J.D. Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial. BMC Pediatr 2008, 8:23.
48. Leach A.J., Morris P.S., McCallum G.B., Wilson C.A., Stubbs L., Beissbarth J., Jacups S., Hare K., Smith-Vaughan H.C. Emerging pneumococcal carriage serotypes in a high-risk population receiving 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001. BMC Infect Dis 2009, 9:121.
49. Gadil G, Morris P, Leach A, Beissbarth J, Halpin S, Hare K, et al. Azithromycin verses amoxycillin for acute otitis media in Aboriginal children (AATAAC): a double blind randomised controlled trial. ISPPD5: 5th International Symposium on Pneumococci and pneumococcal Diseases. ISPPD5, Alice Springs; 2006.
50. Morris P, Leach A, Wilson C, Bailie R. The effect of additional hygiene practices on rates of bacterial cross-infection and respiratory illness in Australian child care centres: a randomised controlled trial, 15th Conference of the International Society for Environmental Epidemiology, Perth, Western Australia; 2003.